BioSpace News Archive

Masimo and Franciscan Missionaries of Our Lady Health System, a 10-hospital system headquartered in Baton Rouge and serving communities throughout Louisiana and Mississippi, have signed a multi-year agreement to implement Masimo monitoring technologies system-wide.

Third Harmonic Bio, Inc. (Nasdaq: THRD), a biopharmaceutical company focused on advancing the next wave of medicine for inflammatory diseases, today announced that Chief Executive Officer Natalie Holles will participate in a fireside chat at the Morgan Stanley Global Healthcare Conference on Tuesday, September 12, 2023, from 7:30-7:55 a.m. ET.

Femasys Inc. announced that it has obtained a Medical Device Establishment License from Health Canada.

Biomea Fusion, Inc. (“Biomea”) (Nasdaq: BMEA), a clinical-stage biopharmaceutical company dedicated to discovering and developing novel covalent small molecules to treat and improve the lives of patients with genetically defined cancers and metabolic diseases, today announced the appointment of Juan Pablo Frías, M.D. as Chief Medical Officer (CMO).

Glucotrack, Inc. (Nasdaq: GCTK) (“Glucotrack” or the “Company”), a medical device company focused on glucose monitoring technologies for people with diabetes and prediabetes, announced today that it has appointed Erin Carter to its Board of Directors and as Chair of its Audit Committee, effective immediately.

Anixa Biosciences, Inc. (“Anixa” or the “Company”) (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer, today announced that management will participate in two investor conferences in September.

The International Myeloma Foundation announced that global leader and patient advocate Emma Hatcher has been named as the IMF’s Global Vice President of Patient Engagement & Advocacy.

Neogen® Corporation (NASDAQ: NEOG) announced today that the Company will participate in the 2023 Wells Fargo Healthcare Conference in Boston, Massachusetts, on Thursday, September 7.

Committed to accelerating progress and expanding access to curative treatment, the National Marrow Donor Program® (NMDP)/Be The Match® is encouraging sickle cell warriors and caregivers to turn to Sickle Cell Warrior Program for free resources, support and for others to join the Be The Match® Registry to potentially save a life.

Viemed Healthcare, Inc., a national leader in respiratory care and technology-enabled home medical equipment services, announced that it will participate in the following upcoming investor conferences.